团体治疗对精神障碍患者代谢综合征的影响价值  

Effect of Group Therapy on Metabolic Syndrome in Patients with Mental Disorders

作　　者：刘巍 张毓茂 郭玉花 LIU Wei;ZHANG Yumao;GUO Yuhua(Department of Psychiatry,the Third Hospital of Nanping,Fujian Province,Nanping 353000,China)

机构地区：[1]福建省南平市第三医院精神科,福建南平353000

出　　处：《中国医药指南》2022年第34期41-44,共4页Guide of China Medicine

摘　　要：目的 探析团体治疗对精神障碍患者代谢综合征的影响价值。方法 以2019年3月为研究起始时间,以2020年2月为研究结束时间,选取此时间段内我院收治的精神障碍代谢综合征患者168例作为研究对象,将其进行编号,即1~168号,其中1~84号归入参考组,并实施常规方式治疗;85~164号归入实践组,在常规方式治疗情况下增加团体治疗。分析两组治疗前和治疗后的精神病症状评分、社会功能变化情况及各项代谢指标水平的差异,计算并比较两组的临床疗效、治疗满意度。结果 治疗前,两组研究对象的精神病症状评分、社会功能变化情况、各项代谢指标水平比较差异无显著性,P>0.05;治疗后,实践组研究对象的精神病症状评分为(50.21±6.17)分、社会功能变化情况评分为(5.28±0.11)分,均低于参考组(t=9.700、11.700,P均<0.05);实践组研究对象的空腹血糖水平为(5.81±0.52)mmol/L、总胆固醇水平为(1.62±0.35)mmol/L、三酰甘油水平为(3.74±0.50)mmol/L、高密度脂蛋白胆固醇水平为(1.53±0.20)mmol/L、低密度脂蛋白胆固醇水平为(2.57±0.33)mmol/L,均优于参考组(t=6.174、5.852、5.120、5.981、6.195,P均<0.05);实践组研究对象的临床疗效为98.81%,高于参考组的89.29%(χ^(2)=6.807,P<0.05);实践组研究对象的治疗满意度为98.81%,高于参考组的89.29%(χ^(2)=6.807,P<0.05)。结论 将团体治疗应用在精神障碍代谢综合征患者治疗中,可有效减轻患者相关症状,改善患者社会功能,调整机体代谢情况,提高临床疗效和治疗满意度。Objective To explore the value of group therapy on metabolic syndrome in patients with mental disorders.Methods With March 2019 as the starting time and February 2020 as the end time of the study,168 patients with mental disorder metabolic syndrome admitted to our hospital during this period were selected as the research subjects and numbered asNo.1-168,No.1-84 among which No.1-84 was assigned to the reference group and received routine treatment.No.85-164 was assigned to the practice group and group treatment was added in case of routine treatment.The psychotic symptom scores,social function changes and differences of various metabolic index levels in different groups before and after treatment were analyzed,and the clinical efficacy and treatment satisfaction were calculated.Results Before relevant treatment,there was no significant difference in psychiatric symptom scores,social function changes and various metabolic index levels between the two groups(P>0.05).After relevant treatment,the psychiatric symptom scores and social function changes of the subjects in the practice group were(50.21±6.17) and(5.28±0.11),respectively,which were lower than those in the reference group(t=9.700 and 11.700,P<0.05).The subjects in the practice group had better fasting blood glucose levels of(5.81±0.52) mmol/L,total cholesterol levels of(1.62±0.35) mmol/L,triglyceride levels of(3.74±0.50) mmol/L,high density lipoprotein cholesterol levels of(1.53±0.20) mmol/L,and low density lipoprotein cholesterol levels of(2.57±0.33) mmol/L than those in the reference group(t=6.174,5.852,5.120,5.981,and 6.195 in sequence,P<0.05).The clinical efficacy of 98.81% in the practice group was higher than 89.29% in the reference group(χ^(2)=6.807,P<0.05).The treatment satisfaction rate of the research subjects in the practice group was 98.81%,which was higher than 89.29% of the reference group(χ^(2)=6.807,P<0.05).Conclusion Group therapy in the treatment of mental disorder metabolic syndrome patients can effectively reduce the related symp

关 键 词：团体治疗 精神障碍 代谢综合征 精神病症状评分 各项代谢指标水平 临床疗效 

分 类 号：R749[医药卫生—神经病学与精神病学]